Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Navigating Emerging Biomarkers in MS Care
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
Discharge Planning After Myasthenic Crisis
Qihua Fan, MD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD
David Weisman, MD
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
The New Era of Targeted Therapy for Myasthenia Gravis
Navigating Emerging Treatment Options in MG
Exploring Genetic Links Between EBV Clearance and MS Risk
New Therapies, New Strategy: Rethinking MG Inpatient Care
Outcome Measures Capture Progression in Late-Onset TK2d
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Ryan Quigley
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.